1. Copies of Biological Medicines: Similar But Not the Same?

   • Pekka Kurki

   Commentary Open access 30 January 2023 Pages: 123 - 126

2. RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis

   • Adam Ioannou
   • Marianna Fontana
   • Julian D. Gillmore

   Review Article Open access 16 February 2023 Pages: 127 - 142

   

3. Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines

   • Bingming Ou
   • Ying Yang
   • Minyu Zhang

   Review Article 06 January 2023 Pages: 143 - 180

   

4. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context

   • Maximilian Ruschig
   • Andrea L. J. Marschall

   Review Article Open access 02 February 2023 Pages: 181 - 203

   

5. Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis

   • HyeJung Na
   • Sun-Hong Kwon
   • Eui-Kyung Lee

   Systematic Review 02 February 2023 Pages: 205 - 218

   

6. Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia

   • László Lorenzovici
   • László Szilberhorn
   • Marcell Csanádi

   Systematic Review Open access 16 February 2023 Pages: 219 - 233

   

7. The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries

   • Kevin Klein
   • Mümün Gencoglu
   • Pieter Stolk

   Original Research Article Open access 06 December 2022 Pages: 235 - 245

   

8. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study

   • Sun-Kyung Lee
   • Kichul Shin
   • Hyoun-Ah Kim

   Original Research Article 09 February 2023 Pages: 247 - 257

   

9. Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial

   • Huiping Li
   • Yan Huang
   • Li Zhang

   Original Research Article Open access 21 February 2023 Pages: 259 - 269

   

10. Consistency of Product Quality for SB5, an Adalimumab Biosimilar

    • JongAh Joanne Lee
    • Nayoung Lee
    • Ilkoo Kim

    Original Research Article Open access 31 January 2023 Pages: 271 - 277